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Genome-wide association study of antisocial personality
disorder
M-R Rautiainen1,2,3,4, T Paunio1,3,4,5, E Repo-Tiihonen2, M Virkkunen3,4, HM Ollila1,6, S Sulkava1,3,4, O Jolanki6, A Palotie5,7,8,9,10 and
J Tiihonen2,11
The pathophysiology of antisocial personality disorder (ASPD) remains unclear. Although the most consistent biological ﬁnding is
reduced grey matter volume in the frontal cortex, about 50% of the total liability to developing ASPD has been attributed to genetic
factors. The contributing genes remain largely unknown. Therefore, we sought to study the genetic background of ASPD. We
conducted a genome-wide association study (GWAS) and a replication analysis of Finnish criminal offenders fulﬁlling DSM-IV criteria
for ASPD (N= 370, N= 5850 for controls, GWAS; N= 173, N= 3766 for controls and replication sample). The GWAS resulted in
suggestive associations of two clusters of single-nucleotide polymorphisms at 6p21.2 and at 6p21.32 at the human leukocyte
antigen (HLA) region. Imputation of HLA alleles revealed an independent association with DRB1*01:01 (odds ratio (OR) = 2.19 (1.53–
3.14), P= 1.9 × 10-5). Two polymorphisms at 6p21.2 LINC00951–LRFN2 gene region were replicated in a separate data set, and
rs4714329 reached genome-wide signiﬁcance (OR = 1.59 (1.37–1.85), P= 1.6 × 10− 9) in the meta-analysis. The risk allele also
associated with antisocial features in the general population conditioned for severe problems in childhood family (β= 0.68,
P= 0.012). Functional analysis in brain tissue in open access GTEx and Braineac databases revealed eQTL associations of rs4714329
with LINC00951 and LRFN2 in cerebellum. In humans, LINC00951 and LRFN2 are both expressed in the brain, especially in the
frontal cortex, which is intriguing considering the role of the frontal cortex in behavior and the neuroanatomical ﬁndings of
reduced gray matter volume in ASPD. To our knowledge, this is the ﬁrst study showing genome-wide signiﬁcant and replicable
ﬁndings on genetic variants associated with any personality disorder.
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INTRODUCTION
Antisocial personality disorder (ASPD) is a life-long condition
involving habitual irresponsible and delinquent behavior, with
prevalence of 1–3% in the general population, and 40–70% in
prison populations.1–5 Previous twin and adoption studies report
heritability estimates for ASPD up to 50%,6,7 and several studies
have attempted to unravel the genetic background of antisocial
personality. Although men have consistently been found more
often antisocial than women, it has been suggested that antisocial
personality emerges from the same familial (including genetic and
environmental factors) and non-familial inﬂuences in both sexes.8
Conduct disorder prior to age 15 is an essential diagnostic
criterion for ASPD, and it markedly increases the risk for ASPD in
adulthood.9 In a recent genome-wide association study (GWAS),
Dick et al.10 found several markers with genome-wide signiﬁcance
associated with conduct disorder symptomatology, especially in
the gene C1QTNF7, although none remained signiﬁcant when
individuals were classiﬁed dichotomously as cases and controls.
Attention-deﬁcit/hyperactivity disorder (ADHD) increases the risk
for ASPD,11 and genes that have been previously found in
association with ADHD have also been tested for association with
ASPD. In a recent study, ADHD linked SNAP25 polymorphisms
(DdeI T/T, MnlI T/T haplotype) were associated with novelty-
seeking scores in male ASPD subjects, and were more common in
ASPD males when compared with sex-matched controls.12
Another candidate gene study revealed an association of COL25A1
variant with comorbid ASPD and substance dependent in a
subpopulation of African American and European American
samples of substance-dependent patients with ASPD.13 In another
recent study, a variant of a previously ADHD linked gene, CDH13,
was associated with extreme violent behavior, and replicated in
another Finnish cohort of violent offenders.4,14 In the same study,
the MAOA low-activity promoter genotype association with violent
criminal behavior was replicated. MAOA deﬁciency was ﬁrst
reported in association with impulsive and aggressive behavior in
a study of a Dutch family cohort,15 and later, MAOA low activity
allele and childhood maltreatment interaction was linked to
antisocial behavior.16 Recently, Tielbeek et al.17 reported the ﬁrst
genome-wide approach in the analysis of population-based
samples of cases with antisocial behavior compared with
population-based controls with only a little or no antisocial
tendencies. Their study revealed no genome-wide signiﬁcant
associations, and the strongest association was observed in
DYRK1A gene (P= 8.70 × 10− 5). In conclusion, although a number
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of studies have investigated antisocial behavior, no genome-wide
signiﬁcant or replicable ﬁndings on genes contributing to ASPD
have been obtained thus far.
Here, our aim was to conduct the ﬁrst GWAS in a cohort of
prisoners fulﬁlling the diagnostic criteria of ASPD according to
DSM-IV as compared to controls from the general population, and
to replicate the most signiﬁcant ﬁndings in another set of
prisoners and controls. We then searched for the impact of the
identiﬁed genetic risk for ASPD for antisocial features and its
interaction with childhood risk environment in the general
population. Finally, we investigated the functional implication of
the risk variations for ASPD by searching for their correlations to
gene expression in human tissue databases.
MATERIALS AND METHODS
Participants
The study population including genotype data consisted of a total of 543
subjects with ASPD and 9616 participants from the general population. The
clinical and sociodemographic characteristics of the participants in this
study are shown in Table 1, and in the ﬂow chart in Figure 1.
CRIME cohort. The Finnish CRIME sample was collected during 2010–
2011, and it comprises 794 samples from all of the largest prisons in
Finland. The sample collecting procedures have been described in more
detail previously.4 In short, prisoners were screened for antisocial
personality utilizing the Structured Clinical Interview Axis II (SCID-II) for
the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Sexual
crime offenders, as well as individuals with diagnosis of psychosis, were
excluded from the sample. Altogether, 568 (500 men, 68 women) criminal
offenders fulﬁlled the criteria for antisocial personality disorder, whereas
196 were classiﬁed as non-antisocial, and 30 criminal offenders had an
unknown ASPD status. Approximately 370 randomly selected individuals
formed the discovery samples with GWAS data available, and 173 were
included in the replication sample. The history of criminal convictions was
Table 1. The clinical and sociodemographic characteristics of the
participants
ASPD (violent criminals,
substance abuse, maltreatment)
Controls
GWAS (N)
Males 339 (265 (NA= 4), 327, 89 (NA= 4)) 3345
Females 31 (20, 31, 13 (NA= 2)) 2505
All 370 (285 (NA= 4), 358, 102 (NA= 6)) 5850
Age (mean± s.d.) 34.5± 8.0 57.4± 13.2
Replication cohort (N)
Males 141 (107 (NA= 2), 134, 37 (NA= 2)) 1587
Females 32 (15 (NA= 2), 27, 7 2179
All 173 (122 (NA= 4), 161, 44 (NA= 2)) 3766
Age (mean± s.d.) 34.2± 9.2 55.0± 17.0
Abbreviations: ASPD, antisocial personality disorder; GWAS, genome-wide
association study; NA, data not available. In the GWAS cohort, data were
unavailable for the ASPD cases for four individuals (all males) on their
violent crimes, and for six individuals (four males, two females) on their
childhood maltreatment. In the replication cohort, the number of
individuals lacking the information on violent crimes was four (two males,
two females), and on their childhood maltreatment two (both males).
Figure 1. The ﬂow-chart of the study. Box (a) illustrates the GWAS analyses including 370 cases (339 males, 31 females) and 5850 controls
(3345 males, 2505 females) from the GenMets (sub sample of Health 2000 study) and Corogene (sub sample of FINRISK study) control samples.
(b) On the basis of the GWAS results, eight variants were selected for analyses in the replication sample composed of those CRIME cases
(N= 173, 141 males, 32 females) and Health 2000 controls (N= 3766, 1587 males, 2179 females) that were not included in the GWAS analyses.
(c) The eight replication variants were included in the meta-analyses of the GWAS sample and the replication sample, including altogether 543
cases and 9616 controls. (d) The most signiﬁcant hit of the analyses, rs4714329, was analyzed in the population sample for the association
with antisocial features (N= 4944, 2211 males, 2733 females), and for the gene x environment interaction of antisocial features and childhood
adverse environment (N= 1536, 636 males, 900 females). GWAS, genome-wide association studies. HLA, human leukocyte antigen; LD, linkage
disequalibrium; MAF, minor allele frequency.
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obtained from the National Crime Register, and 77% of the antisocial
prisoners were violent offenders having committed at least one violent
crime. The remaining individuals of the ASPD sample were offenders who
had been convicted for non-violent crimes, such as house break-ins or
crimes against property. The history of substance abuse (alcohol, heroin,
buprenorphine, amphetamine, cannabis and/or other) as well as childhood
circumstances (for example, good circumstances, indifferent parents or
severe maltreatment such as family violence) were screened with a
questionnaire. Subjects provided a written informed consent. This study
was approved by the Ethics Committee for Pediatrics, Adolescent Medicine
and Psychiatry, Hospital District of Helsinki and Uusimaa, and Criminal
Sanctions Agency. All the subjects who participated in the study received a
voucher of 20 euros for their participation.
Control cohorts. The Health 2000 Study, including the GenMets sub
cohort, and The National FINRISK Study, including the Corogene sub
cohort, were used as control cohorts in the study (N=5850 with GWAS
data available, used in the discovery phase; and N= 3766 in the replication
analysis; Supplementary Information).
Phenotypes
Phenotype in GWAS, replication and secondary analyses of the ASPD
sample. The subjects of the CRIME cohort, who fulﬁlled the criteria for
ASPD according to DSM-IV and diagnosed by SCID-II were classiﬁed
as cases. In addition, 22 individual items of the SCID-II questionnaire for
ASPD were used in secondary analyses and analyzed individually. The
phenotypes are described in detail in the Supplementary Information.
Phenotype in the secondary analyses of the population-based sample. The
phenotype of antisocial features in the Health 2000 cohort was assessed
with a scale, which is part of the home interview of the Health 2000 survey.
The scale is originally from a 50-item scale, ‘Cook-Medley hostility
scale’,18,19 and it included eight questions focusing on the aspects of
deceitfulness, distrust to other people, and lack of empathy. Information
on the childhood environment of economic difﬁculties or severe conﬂicts
in the family were questioned and applied in gene-environment
interaction analyses (Supplementary Information).
Genotyping and statistical analyses
Genotyping. Illumina Human670QuadCustom Beadchip and
HumanHap610-Quad SNP array (Illumina, San Diego, CA, USA) were used
for genotyping of common single-nucleotide polymorphisms (SNPs)
genome-wide at the Welcome Trust Sanger Institute, Cambridge, UK for
the CRIME and control cohorts, respectively. Stringent quality control was
used and only SNPs originally included in all data sets of controls and cases
were analyzed, resulting in 481866 SNPs in the ﬁnal data set. Targeted
genotyping for both controls and cases were performed by Sequenom
MassARRAY iPLEX technology (San Diego, CA, USA) simultaneously at the
Institute for Molecular Medicine, Finland (for details on genotyping, see
Supplementary Information).
HLA-imputation. Imputation of the GWAS genotype data with the
classical human leukocyte antigen (HLA) alleles was performed utilizing
the HIBAG software20 (for more information, see Supplementary
Information).
Statistical analyses and linkage disequilibrium analyses. The power
calculations were performed utilizing Genetic Power Calculator (http://
pngu.mgh.harvard.edu/ ~ purcell/gpc/).21 All of the association analyses
were performed using a generalized linear (logistic) model with PLINK
v1.07 (http://pngu.mgh.harvard.edu/ ~ purcell/plink/)22 with age and
sex and the 10 ﬁrst multidimensional scaling clusters as covariates.
The meta-analyses with ﬁxed effect model were performed with
GWAMA software (http://www.geenivaramu.ee/en/tools/gwama.23 SPSS
(IBM Released 2013. IBM SPSS Statistics for Windows, Version 22.0.
Armonk, NY, USA). The linkage disequilibrium (LD) and haplotype
analyses were performed utilizing PLINK v1.07, Haploview,24 and SNAP
(https://www.broadinstitute.org/mpg/snap/).25 Detailed description of the
statistical analyses can be found in the Supplementary Information.
Gene expression analyses
The GTEx Portal (http://www.gtexportal.org/home/)26 and The Braineac—
the Brain eQTL Almanac (http://www.braineac.org/) were utilized to
investigate correlations between variant genotype and brain- and testis-
tissue gene-expression levels. More information can be found in the
Supplementary Information.
RESULTS
GWAS for ASPD
We conducted genome-wide association analyses, for DSM-IV
based ASPD, using the entire GWAS study sample (N cases = 370,
N controls = 5850), as well as in the sample including only males
(N cases = 339, N controls = 3345). The number of the female cases
was too small (N= 31) to perform a separate analysis. The
Manhattan plots for the genome-wide analyses are presented in
Figure 2, illustrating the results of the analyses for the whole
sample, and the sample including only males, respectively.
Supplementary Tables 1a and 1b display the most signiﬁcant 50
variants associated with antisocial personality disorder in the
combined sample, and in males, respectively. None of the
associations achieved genome-wide signiﬁcance (Po5.0 × 10− 8).
However, in the quantile-quantile (Q–Q) plots for the observed
versus expected results (−10 log(P-value)), for both analyses,
several data points were observed above the lift of line indicating
more signiﬁcant associations than expected by chance
(Supplementary Figures 1a and b).
The strongest signal for association in the combined analysis of
males and females was detected in chromosome 7p22.2, in the
vicinity the SDK1 gene, for rs6462756 (odds ratio (OR) = 1.84 (1.45–
2.33), P= 5.5 × 10− 7). As no other variant within 500 kb (250 kb
down/upstream, including 135 SNPs) of it gave any signal, it was
considered spurious, and was not selected for replication in this
study. The next strongest associations were observed for
rs9268528 (OR= 0.58 (0.46–0.72), P= 9.9 × 10− 7) and rs9268542
(OR= 0.58 (0.46–0.72), P= 1.1 × 10− 6), located on chromosome
6p21.32, intragenic of the BNTL2 and HLA-DRA genes. These two
variants were selected for replication, together with an additional
nearby intragenic variant, rs2395163 (OR= 0.59 (0.46–0.77),
P= 6.2 × 10− 5), and an intronic variant of HLA-DRA gene,
rs2239804 (OR= 0.61 (0.49–0.77), P= 1.2 × 10− 5). All the associa-
tion signals of these variants in the vicinity of the HLA-DRA gene
originated from the major allele. Supplementary Figure 2a shows
the regional Manhattan plot of chromosome 6 for the analysis of
the whole sample.
In the analysis of the males alone, the strongest association
signals were observed for variant rs6458146 (OR= 1.72 (1.40–2.13),
P= 3.9 × 10− 7), residing in an intergenic region on chromosome
6p21.2. An additional four markers in nearby loci gave signal with
P-valueso5 × 10− 5 (rs9471290, OR = 1.68 (1.37–2.06),
P= 8.1 × 10− 7; rs10498746, OR= 1.72 (1.38–2.13), P= 9.9 × 10− 7,
rs7749170, OR= 1.67 (1.35–2.08), P= 3.8 × 10− 6; rs4714329, OR=
1.56 (1.27–1.92), P= 2.5 × 10− 5). Supplementary Figure 2b shows
the regional plot for the males’ association analysis.
Overall, our ﬁndings suggest altogether eight variants that
associated with ASPD, originating from distinctive regions located
at 6p21 (6p21.2 and 6p21.32). These were chosen for the
regenotyping and for the replication analyses.
Regenotyping, replication and meta-analysis
Re-genotyping and conﬁrmatory analyses. In order to conﬁrm the
consistency of the genotypes from the GWA analyses, we
performed simultaneous regenotyping of the selected eight
variants both in the CRIME sample as well as in the GenMets
controls from Health2000 (Genmets sample) by another technol-
ogy (Sequenom MassARRAY iPLEX). There was a 499% similarity
between the original genotypes from GWAS in the discovery
Genome-wide association study of antisocial personality disorder
M-R Rautiainen et al
3
Translational Psychiatry (2016), 1 – 10
analysis and in the regenotyping (Supplementary Information).
Thus, the original signals from the GWAS on 6p21.2 and 6p21.32
were not due to spurious genotyping errors.
We also compared the minor allele frequencies (MAFs) of these
variants in our cases, as well as their controls from the HapMap-CEU
population (http://www.ncbi.nlm.nih.gov/SNP/) (Supplementary
Table 4). The MAFs for all these eight SNPs were relatively
consistent between the population controls of GWAS and of
replication samples. When looking the genetic variation at these
chromosomal regions more widely, the MAFs for the variants on
6p21.2 were well in line with the HapMap-CEU. The MAFs of the
variants near the HLA-DRA gene, on 6p21.32, were considerably
lower in both of the GWAS and replication population controls as
compared with the HapMap-CEU. This is likely to reﬂect the
genetically complicated nature of that particular chromosomal
region with widely extending structures of LD and with high
variation in different populations.
Replication analysis. Table 2 shows the results among the
discovery sub-cohort (N cases = 370, N controls = 5850) and the
replication sub-cohort (N cases = 173, N controls = 3766), and the
entire study population (meta-analysis; N cases = 543, N controls =
9616). The variants on 6p21.2 showed a consistent signal in the
replication analysis (rs7749170 failed in the Sequenom genotyping
and is therefore absent), whereas the results for the SNPs on
6p21.32 were diluted or reversed when compared to the GWAS
signal. Two out of four of the SNPs on 6p21.2 showed a statistically
signiﬁcant signal in the replication analysis (males and females
combined). The most signiﬁcant signals on 6p21.2 were revealed
for rs4714329 (OR= 1.75 (1.37–2.24), P= 9.0 × 10− 6) and for
rs9471290 (OR= 1.40 (1.09–1.81), P= 8.3 × 10− 3). The replicating
variants were included in a meta-analysis in which rs4714329
yielded an OR of 1.59 (1.37–1.85) and P-value of 1.6 × 10− 9, and
rs9471290 had an OR of 1.49 (1.28–1.73) and a P-value of
2.9 × 10− 7. A post hoc replication analysis of rs4714329 in the
female sample (N cases = 32, N controls = 2179) revealed an OR of
2.55 (1.50–4.33) and a P-value of 5.3 × 10− 4. Thus, we detected a
replication with two variants at 6p21.2, the most robust ﬁnding
with rs4714329 reaching genome-wide signiﬁcance (P= 1.6 × 10− 9
in the meta-analysis), although there was evidence that variants
on 6p21.32 were weaker according to the replication study.
LD and haplotype analyses on 6p21.2 and 6p21.32
LD and haplotype analysis on 6p21.2. To investigate whether the
most signiﬁcant variant from the meta-analysis (rs4714329)
belonged to a longer haplotype, we performed LD and haplotype
analyses for all of the four SNPs residing in the 6p21.2 genomic
region. Two of the variants (rs6458146 and rs10498746) were
Figure 2. Manhattan plot of the entire sample of males and females combined in the analysis of the ASPD cases versus population-based
controls (a) and for the males’ sub-sample (b). ASPD, antisocial personality disorder.
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located in the same haploblock (bp 40218128–40224268, GRCh37;
Supplementary Figure 3). Also, rs9471290 (bp 40260515) was in a
strong LD with those (D′= 0.93 and 0.95, and LOD⩾ 2.0,
respectively). Rs4714329 was, however, only in a moderate LD
with the other 6p21.2 variants (D′= 0.77, 0.68, and 0.66 to
rs9471290, rs6458146 and rs10498746, respectively). A post hoc
haplotype analysis of the SNPs with the most signiﬁcant signal
from the replication analysis yielded an association signal from a
relatively frequent (f= 0.31) haplotype of minor alleles A–G
(rs9471290 and rs4714329, respectively) of OR = 1.59
(P= 5.6 × 10− 6) in the GWAS data, and of OR= 1.49 (P= 0.0022)
in the replication cohort (males and females combined). Thus, the
signal for association from 6p21.2 was not strengthened by the
haplotype and the risk genotype was best captured by the G-allele
of rs4714329.
In an effort to further elucidate the possible origin of the signal
of our best hit, we investigated the LD between rs4714329 and the
variants within the nearby genes (RP11-552E20.1, TDRG1,
LINC00951 and LRFN2) utilizing the GWAS variant data of the
CRIME cohort as well as the HapMap3 project data and the 1000
Genomes Pilot 1 data (Supplementary Information). The strongest
LD was observed between rs4714329 and several variants of
the LINC00951 gene, consistently in all three data sets. In addition,
the CRIME sample LINC00951 gene variants (rs17619142 and
rs17619309) revealed nominal association with ASPD (OR of 1.18
and 1.5, and P value of 0.002 and 0.159, respectively), which
supported the role of LINC00951 as the strongest candidate of the
nearby genes for the signal origin.
LD analysis on 6p21.2 and 6p21.32. As stated earlier, the HLA
region at 6p21.32 is known for its complexity and extended LD
ranging across multiple HLA and non-HLA genes in the region,
and the HLA alleles may be captured by tag SNPs even outside
the region.23 As the two most signiﬁcant sets of variants with
leading SNPs (rs4714329 at 6p21.2 and rs9268528 at 6p21.32)
resided only approximately 8 Mb distance from each other, we
investigated whether there would be LD between them. We also
analyzed their haploblock structures, and which other SNPs would
tag them in the data. Although the variants were strongly linked
within the set, especially on the 6p21.32 loci, there was no LD
between the two sets. Furthermore, they did not share same
haploblocks, and no tagging was evident across the two sets (data
not shown).
Analysis of HLA alleles at 6p21.32. The HLA region is highly
polymorphic and individual SNPs at the HLA region are commonly
part of more than one HLA allele and haplotype. The GWAS
analysis of the associating locus (6p21.32) at the HLA region
showed multiple SNPs associating with ASPD and the LD was
carried over from BTNL2 gene to as far as the HLA-DQB1 gene
region (Figure 3b). We observed that there were no directly
genotyped SNPs at the HLA-DRB1 locus that would conceivably
have depicted whether the highest association was indeed over
HLA-DRA or perhaps over the HLA-DRB1 locus. It was also possible
that some of the associating SNPs tagged an independent HLA
allele, or that speciﬁc HLA alleles or their coding polymorphisms,
rather than single SNPs, would drive the association with ASPD.
The HLA region is also known to be difﬁcult for probe designing or
to impute with SNPs, therefore, we imputed the GWAS genotype
data with the classical HLA alleles (Supplementary Information),
and studied whether speciﬁc HLA alleles would associate with
ASPD. We detected four HLA alleles at HLA-DRB1 and HLA-DQA1
genes with similar signiﬁcance as individual SNPs but with higher
OR in association with ASPD (Supplementary Table 2). The
strongest associations were seen with a common HLA-DRB1 allele
DRB1*01:01 (OR= 2.19 (1.53–3.14), P= 1.9 × 10− 5, f= 0.17) and with
DQA1*01:01 (OR = 2.09 (1.46–2.99), P= 5.6 × 10− 5, f= 0.17) that are
known to be in tight LD (current data r2 = 0.981). In addition,
protective associations with DRB1*04:04 and DQB1*03:02 alleles
were detected with similar protective effects as the strongest
individual SNPs of the GWAS analysis (DRB1*04:04 OR=0.39 (0.18–
0.57), P= 9.7 × 10− 5, f= 0.04 and DQB1*03:02 OR=0.52 (0.37–0.74),
P= 2.5 × 10− 4, f= 0.11). To investigate whether the HLA allele
effects were directly explained by the individual SNPs, we
conditioned the analysis for the strongest variant at the HLA
region (rs9268528), which failed to remove the association with
DRB1*01:01 (conditioned P= 2.3 × 10− 3). Similarly, conditioning for
the strongest four HLA alleles failed to remove the association
with rs9268528, suggesting independent roles for the HLA alleles
and rs9268528 in ASPD.
As individual amino acids coded by the HLA genes have been
previously indicated to drive disease association,27,28 we examined
whether the associations of the top SNPs could be explained by
individual coding polymorphisms at the HLA-DRB1 or DQA1 alleles
(Supplementary Table 3). The DRB1 position 11 V was observed
with the strongest protection for ASPD (OR= 0.49 (0.37–0.66),
P= 2.4 × 10− 6). Interestingly, DRB1 position 11 V is detected here
with those DRB1*04 alleles that were associated at the allele level.
In addition, DRB1 position 11 V was in relatively high LD with
rs2395163 (D′= 0.83, r2 = 0.56). Conditioning for position 11 V
removed the association with rs2395163, but not with the leading
variant at the HLA region (rs9268528 conditioned P= 8.3 × 10− 3)
or with DRB1*01:01 (conditioned P= 5.2 × 10− 4), which was the
strongest association at the HLA-region after conditioning for
DRB1 position 11 V. Finally, we studied whether DRB1 position
11 V, together with HLA-DRB1*01:01, would explain the association
with rs9268528. This was not the case. Even though the P-value for
rs9268528 association was weaker after conditioning for both HLA-
DRB1*01:01 and for DRB1 position 11 V, it was still signiﬁcant with
a point-wise P-valueo0.05.
Analyses for sensitivity and the individual SCID-II items
Association sensitivity. Given that the main focus of this study is
ASPD, cases were selected from the whole of the CRIME cohort
based on the SCID-II diagnostics. However, the non-ASPD
criminals group may include cases near the ASPD diagnosis cut-
off threshold. Thus, we performed an analysis on non-ASPD status
(all males, N= 129) to examine whether the signal from the
selected eight variants was speciﬁc for ASPD or if it covered a
broader range of criminal activity. No association signal was
detected for any of the selected variants. As substance abuse, as
well as violent behavior, is linked to antisocial personality disorder,
we performed sensitivity analyses including only those ASPD cases
with substance abuse (N= 358, males = 327) or violent crime
(N= 285, males = 265). Among substance abusers, a slight
strengthening of the signal for the variants near the HLA-DRA
gene on 6p21.32 was observed, but the signal was diluted for the
variants on 6p21.2 (data not shown). Among violent criminals, the
signals from all of the variants were diluted (data not shown).
Individual SCID-II items. ASPD diagnosis is based on a relatively
broad range of antisocial behavioral characteristics. To elucidate
the origin of the strong association signal arising from rs4714329
to ASPD, we analyzed each 22 characterizing items of the SCID II
questionnaire individually (Supplementary Information; page 1,
Supplementary Tables 7 and 8 and Supplementary Figure 5). The
odds ratios for all of the 22 questions were quite similar, ranging
between 1.4 and 1.7. The most signiﬁcant association was
achieved for item (20), ‘Reckless disregard for safety of self or
others’ with the OR of 1.66 (1.41–1.94) and a P-value of 6.0 × 10− 10
(heterogeneity index I2 = 0.44 (scale 0–1), indicating more varia-
tion than expected by chance) in the meta-analysis (N cases = 477,
N controls = 9616). The most signiﬁcant association with the
heterogeneity index value of zero was observed for item (16),
‘Failure to conform to social norms with respect to lawful
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behaviors, as indicated by repeatedly performing acts that are
ground for arrest’ (OR = 1.60 (1.37–1.87), P= 1.7 × 10− 9, N cases =
529, N controls = 9616). The most signiﬁcant items typically
included 4400 individuals each, whereas some of the items,
such as items (5) or (8) only included o100 individuals, hence, the
P-values here should preferably be interpreted as a reﬂection of
power. Consequently, rs4714329 was found to be broadly
associated with the different aspects of ASPD.
Figure 3. Association peaks at the chr 6 LINC00951 (a) and HLA (b) regions. Extended LD over the HLA class II region can be observed in b.
HLA, human leukocyte antigen; LD, linkage disequalibrium; SNP, single nucleotide polymorphism.
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Association of rs4714329 to antisocial features in general
population
The prevalence of ASPD is low in the population (1–3%),1 with a
well-established role of early adverse environment in its
etiology.29,30 We hypothesized that the most signiﬁcant hit in
the ASPD analyses, the risk allele G of rs4714329, would also have
an impact on antisocial features in the general population,
especially among those individuals who had encountered severe
difﬁculties in their childhood. Thus, we tested the risk variant in
the Health 2000 population sample for association with antisocial
tendencies, and also performed a gene× environment interaction
analysis, where reported severe conﬂicts or economic difﬁculties
in the childhood family were considered as a risk environment.
As a measure of antisocial features, we utilized a scale assessed in
the Health 2000 survey and focusing on deceitfulness, distrust
to other people, and lack of empathy (see Supplementary
Information for phenotype in the secondary analysis of the
population-based sample). No signal was detected for the main
effect of antisocial features in the complete sample (males and
females: N= 4944, β= 0.13, P= 0.175; males only: N= 2211,
β= 0.203, P= 0.143). However, there was a modest signal for
interaction between the risk environment and rs4714329 in males,
but not in females, in the general population (males: a β of 0.647,
and a P-value of 0.045 for the interaction term), and the risk allele
G associated signiﬁcantly with antisocial features among males
with the childhood risk environment (N= 636, β= 0.68, P= 0.012).
Expression analysis of rs4714329 in brain tissue databases
The most signiﬁcant variant of the replication and meta-analyses
for ASPD, rs4714329 resides in the proximity of the genes
LINC00951, LRFN2, RP11-552E20.1 and TDRG1. LINC00951 and
LRFN2 are expressed mostly in the brain, especially in the cortex
and testis. TDRG1 gene is expressed mostly in testis and in the
brain. Thus, we investigated in the GTEx Portal and in the Braineac
database the possible association of rs4714329 with the nearby
residing genes’ expression levels in all of the available brain
tissues and in testis (testis only in the GTEx Portal; Supplementary
Information).
In the GTEx Portal, the most signiﬁcant association was
achieved with LINC00951 gene expression in cerebellum
(N= 103) with the β of 0.51 and a P-value of 2.0 × 10− 6. LRFN2
and TDRG1 gene expressions revealed association in the cerebellar
hemisphere (N= 89; P-value = 2.0 × 10− 5 and β= 0.56,
P= 4.0 × 10− 5 and β= 0.51, respectively; Supplementary Table
6a). In Braineac, no data were available for LINC00951, but
rs4714329 was associated most signiﬁcantly (P= 7.4 × 10− 4) with
LRFN2 expression in cerebellum (N= 130), although consistently
with the GTEx Portal, LRFN2 is mostly expressed in the cortex. For
TDRG1 expression in Braineac, the most signiﬁcant (P= 3.8 × 10− 3)
association was observed in occipital cortex (OCTX, N= 129;
Supplementary Table 6b). Neither databases had data available for
RP11-552E20.1 gene expression; in Braineac, no data were
available for LINC00951, and RP11-552E20.1 genes. Thus, the
results revealed that rs4714329 associated to expression of the
nearby located genes in brain so that the risk allele G of rs4714329
was found to correlate with reduced levels of LINC00951, LFRN2
and TRG1 mRNAs in cerebellum and of TDRG1 in occipital cortex.
DISCUSSION
The results from this ﬁrst GWAS on ASPD reveal genome-wide
signiﬁcant and replicable associations for variants residing on
chromosome 6p21.2. According to our linkage investigation, our
best hit, rs4714329 is in considerable LD with several polymorph-
isms of the LINC00951 gene, and not up to the same level with the
polymorphisms of the other genes in that genomic region,
suggesting that the LINC00951 gene is the strongest candidate for
the signal origin. However, analysis of the gene expression data
from the GTEx and Braineac databases revealed equally strong
associations between rs4714329 and the expression levels of three
nearby genes, namely LINC00951, LRFN2 and TDRG1, in tissues
from cerebellum, of which the LINC00951 association was the
strongest in the cerebellum and LRFN2 in the cerebellar hemi-
sphere. Although cerebellum has traditionally been linked to
motor control, it has also been suggested to be involved in
cognition31 and personality,32 as well as autism spectrum
disorders33 and psychosis.34 Most interestingly, Leutgeb et al.
reported an altered cerebellum–amygdala connectivity among
violent offenders, although their study excluded psychopathic or
personality-disordered individuals.35 Although there was no
correlation of rs4714329 to RNA levels in frontal cortex, it is
highly interesting that the general levels of the transcripts for both
LINC00951 and LRFN2 are particularly high in frontal cortex,36,37 as
the reduced GMV at that particular cortical region is one of the
most consistently-reported biological ﬁndings in ASPD.38,39
Chromosomes 6p21.2 and 6p21.32 belong to the chromosomal
region of major histocompatibility complex, and have been pre-
viously linked to psychiatric disorders including schizophrenia6,40
and bipolar affective disorder,41 as well as neurologic disease such
as photosensitive epilepsy,42 late-onset Alzheimer disease43 and
restless legs syndrome.44 In this study, we discovered novel
suggestive associations of HLA-DRB1*01:01 and DRB1*04:04 with
ASPD. Previous studies have reported the same alleles in
association with schizophrenia,45–47 whereas other studies have
not been able to replicate those ﬁndings48 and the link has
remained controversial. In this study, additional analysis of coding
polymorphisms suggested an independent role for Valine at
position 11 on DRB1 that was tagged by one of the most
signiﬁcant GWAS hits in this study, rs2395163. The ﬁndings
suggest that ASPD may share genetic risk factors in this locus with
other psychiatric and neurological disorders.
The study sample in this study overlapped partially with the
sample in a previous study of extreme violent behavior.4 However,
the signiﬁcant variants were not associated with violent offending
in general, which indicates that the variants were associated with
ASPD per se. This conclusion is also supported by the ﬁnding on
antisocial attitudes observed in the cohort from the general
population, where the risk allele was found to increase the
presence of the antisocial features of deceitfulness and lack of
empathy among those individuals who reported severe family
conﬂicts or economic difﬁculties in their childhood families.
The ASPD diagnosis is controversial, since many clinicians and
researchers think that the category is too heterogeneous and has
overlap with other disorders.30 ASPD and other personality
disorders have been reported to have comorbidity with psycho-
pathy, a personality trait tightly connected to criminality and
forensic psychiatry.5,49 Although ASPD and psychopathy diag-
noses are based on different assessment tools, the distinction
between those two is not completely clear.50,51 We consider our
study sample relatively homogenous as the participants were all
criminal offenders and had a convergent diagnosed ASPD.
However, to further study the behavioral origin of our genome-
wide signiﬁcant hit, rs4714329, we investigated its association
individually with each of the SCID II items used in this study. All of
the 22 items gave consistent ORs, indicating that the original
signal covers all the different aspects of ASPD according to DSM-
IV, supporting the homogeneity of the study sample. However, we
would like to point out, that the most signiﬁcant associations were
observed for those items that particularly describe social learning.
Association with weak learning from social feedback would seem
very logical for different frontal cortex genetic regulation, but it
may also reﬂect those in cerebellum. It has also been reported that
21–45% of the prison inmates have a comorbid ADHD,52,53 and a
shared etiology has been suggested for such externalizing
phenotypes as adult substance use and antisocial personality,
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and childhood conduct disorder and ADHD.54–56 ADHD was not
diagnosed in our study sample, however, ~ 96% of the analyzed
sample were substance abusers. The externalizing dimension of
behavior is hypothesized to reﬂect an inherited predisposition for
developing one or more of the aforementioned disorders.57 Thus,
the previous ﬁndings on reduced GMV in frontal brain areas
associated with ASPD may also reﬂect the comorbidity of the
externalizing problems, consistent with the ﬁndings of ADHD
prevalence in prisoners and supported by our ﬁndings here.
There were limitations in the study. In the GWAS study, the
CRIME sample was genotyped with a different array than the
control samples (GenMets, Corogene), although in the same
facility of Welcome Trust Sanger Institute. Therefore, only the SNPs
that overlapped in all of the three genotyping data sets were
included in the analyses and even unusually stringent thresholds
were used in the quality control. Furthermore, the regenotyping of
the eight replication variants in the CRIME subjects and GenMets
controls that were included in the GWAS, revealed practically
identical genotypes as the GWAS genotyping with 499%
concordance between the two methods. In a post hoc repeat
GWAS analysis, including the CRIME subjects and GenMets
controls, the results were consistent with the original analysis.
This also indicated that had there been discrepancy with the
Corogene control sample genotypes of the eight SNPs in the
GWAS, this would have shown in the repeat analysis results. In
spite of intensive QC, spurious associations may occur. We
considered the top variant (rs6462756, near SDK1 gene) of the
analysis of males and females combined as a plausible false
positive, as it was the only signal from that genomic region
(7p22.2), where the SNP density was not particularly sparse, rather
to the contrary, relatively dense (35 SNPs per 100 kb, compared
with chr 7p average 21 SNPs per 100 kb and the nearby 500 kb
average 25 SNPs per 100 kb), and thus, it was not selected to the
regenotyping nor to the replication study.
Another factor raising concerns regards the reversed replication
results of the set of hits on 6p21.32, near HLA-DRA gene. A
possible explanation may lie in the high gene density and
polymorphism rate of the HLA region, combined with the lack of
power in this study. The MAF investigation of the eight variants,
including the HapMap-CEU population sample, revealed consider-
able MAF variance for the HLA-DRA variants, but not for the
variants on 6p21.2, near to the LINC00951 gene. The only variant in
the HLA-DR region on 6p21.32 showing similar MAF in discovery
and replication was rs2395163 that tagged a relatively rare HLA-
DRB1*04:04 association. As the allele frequency of HLA-DRB1*04:04
was only 0.04, it was not surprising that the association was not
replicated in the relatively small replication sample. However, it is
important to emphasize that the HLA-ﬁndings emerge only from
the imputed GWAS data, and no replication was addressed in
this study.
These ﬁndings are limited to the Finnish population-based
cohorts, and therefore replications in other samples of other
populations should be pursued. With altogether 543 cases and
9616 controls, our study remains very much underpowered, as
indicated in the power calculations. Bigger sample sizes are
needed, although collection of large samples is rather demanding,
and especially for behavioral phenotypes of a relatively special
nature, such as ASPD, large samples may materialize at the
expense of phenotype homogeneity. The large GWAS’s have
proven the method a useful tool for identifying genetic loci in
complex disease of small individual factor effect sizes, such as in
schizophrenia.34 However, GWAS in smaller samples may also
reveal important associations, particularly, when the phenotype is
accurate, and the suggestive ﬁndings may be of value for future
studies with larger sample sizes.
The results of this study need to be interpreted carefully. There
are examples of how the genetic associations of ASPD may be or
have been misused for prediction purposes or in courthouses.58,59
The concept of heritability is sometimes misinterpreted. When
ASPD is described as 50% heritable, it implicates that heritability
explains 50% of the variance in that population in which the study
was conducted in, and not that on the individual level an ASPD
subject had inherited 50% of the disorder from their parents and
50% was due to the environmental inﬂuences. The ﬁndings of this
study cannot be implemented for any prediction purposes, or
brought into courthouses to be given any legal weight. Instead,
this study serves well as a candidate variant reservoir for
personality traits and disorders adding to the few candidate
variants that have previously existed for ASPD. Important next
steps would be to discover the causal factors tagged by the
ﬁndings here and to elucidate the molecular functions involved
with ASPD. In conclusion, our results showed a robust signal for
several variants located beside LINC00951 with potential func-
tional effects. To our knowledge, this is the ﬁrst study showing
genome-wide signiﬁcant and replicable ﬁndings on genetic
variants associated with any personality disorder.
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